Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by Hologic, Inc. of $350 million aggregate principal amount of its 4.375% senior notes due 2025. Hologic intends to use the net proceeds from the offering and available cash to repurchase all of its outstanding convertible notes.

Based in Marlborough, Massachusetts, Hologic is a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. Hologic operates in five core business segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health.

The Davis Polk capital markets team included partner Michael Kaplan and associates Milson C. Yu and Heita Miki. The tax team included partner Michael Farber. The environmental team included counsel Loyti Cheng and associate Michael Comstock. Partner Pritesh P. Shah and associate Carrie Guo provided intellectual property and technology advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post